Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk.
Hyperglycemia is a major risk factor for both the microvascular and macrovascular complications in patients with type 2 diabetes. This review summarizes the cardiovascular results of large outcomes trials in diabetes and presents new evidence on the role of hyperglycemia, with particular emphasis on postprandial hyperglycemia, in adverse cardiovascular outcomes in patients with type 2 diabetes. Treatment options, including the new dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 mimetics that primarily target postprandial hyperglycemia, are also discussed. Hyperglycemia increases cardiovascular mortality, and reducing hyperglycemia lowers cardiovascular risk parameters. Control of both fasting and postprandial hyperglycemia is necessary to achieve optimal glycated hemoglobin control. Therefore, anti-hyperglycemic agents that preferentially target postprandial hyperglycemia, along with those that preferentially target fasting hyperglycemia, are strongly suggested to optimize individual diabetes treatment strategies and reduce complications.
Aryangat
Ajikumar V
AV
University of Rochester, Rochester, New York 14642, USA.
Gerich
John E
JE
D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003925:Diabetic Angiopathies / Q000209:etiology* / Q000517:prevention & control; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use; D005215:Fasting / Q000097:blood; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D012306:Risk
D054873:Dipeptidyl-Peptidase IV Inhibitors; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents
Diabetes Res Clin Pract. 2007 Apr;76(1):132-8
17223217
Arch Intern Med. 2003 Jun 9;163(11):1306-16
12796066
Diabetes Care. 2009 Jan;32 Suppl 1:S13-61
19118286
Lancet. 2009 Nov 14;374(9702):1677-86
19878986
Diabetes Res Clin Pract. 2007 Aug;77(2):280-5
17240473
Stroke. 2004 May;35(5):1073-8
15073402
N Engl J Med. 2009 Jan 8;360(2):129-39
19092145
Diabetes Care. 2007 Jun;30(6):1608-10
17372153
Diabetes Obes Metab. 2008 May;10(5):376-86
18355324
JAMA. 2003 Jul 23;290(4):486-94
12876091
Diabetes Res Clin Pract. 2007 Jul;77(1):1-15
17112621
JAMA. 2008 Jan 23;299(3):316-23
18212316
J Clin Endocrinol Metab. 2006 Mar;91(3):837-42
16368744
N Engl J Med. 2005 Dec 22;353(25):2643-53
16371630
Diabetes Care. 2005 Apr;28(4):888-94
15793191
Br J Gen Pract. 2008 Aug;58(553):535-40
18682011
Clin Drug Investig. 2008;28(4):199-210
18345710
Diabetes Care. 2009 Jan;32(1):193-203
18945920
BMJ. 2008 Jul 01;337:a236
18595902
Curr Atheroscler Rep. 2009 Nov;11(6):462-9
19852888
Eur Heart J. 2005 Apr;26(7):650-61
15728645
Lancet. 1998 Sep 12;352(9131):837-53
9742976
Diabetes Care. 2003 Sep;26(9):2518-23
12941712
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7988-95
12810946
Circulation. 2001 Mar 27;103(12):1618-23
11273987
N Engl J Med. 2008 Jun 12;358(24):2545-59
18539917
Diabetes Care. 2009 Oct;32(10):1820-2
19592631
Diabetes Care. 2008 Feb;31 Suppl 2:S150-4
18227477
Am J Manag Care. 2008 Sep;14(9):589-96
18778174
Diabetes Care. 2002 Dec;25(12):2165-71
12453955
JAMA. 2006 Apr 12;295(14):1681-7
16609090
Am J Prev Med. 2008 Oct;35(4):357-63
18779029
Circ J. 2007 Jul;71(7):1079-85
17587714
Lancet. 2006 Nov 11;368(9548):1696-705
17098089
Am J Clin Nutr. 2008 Mar;87(3):627-37
18326601
Int J Technol Assess Health Care. 2007 Spring;23(2):177-83
17493303
Diabetes Care. 2003 Mar;26(3):881-5
12610053
Diabetes Care. 2006 Dec;29(12):2632-7
17130196
QJM. 2008 Jul;101(7):513-8
18319293
N Engl J Med. 2004 Dec 23;351(26):2683-93
15616203
Diabetes Care. 2002 Mar;25(3):608-13
11874956
Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2456-62
17872451
Diabetes. 2008 May;57(5):1349-54
18299315
Exp Clin Endocrinol Diabetes. 2006 Sep;114(8):417-23
17039422
J Clin Endocrinol Metab. 2008 Apr;93(4):1345-50
18198229
Diabetes. 2006 Feb;55(2):480-6
16443784
JAMA. 2002 May 15;287(19):2563-9
12020338
Endocr Pract. 2007 May-Jun;13 Suppl 1:1-68
17613449
Circulation. 2005 Jul 12;112(2):179-84
15998667
Diabetes Care. 2003 Oct;26(10):2929-40
14514604
Lancet. 2004 Sep 11-17;364(9438):937-52
15364185
Diabetes Care. 1999 Jun;22(6):920-4
10372242
Diabetes. 1990 Nov;39(11):1381-90
2121568
N Engl J Med. 2008 Oct 9;359(15):1577-89
18784090
J Am Diet Assoc. 2008 Apr;108(4 Suppl 1):S24-8
18358250
Diabetes Care. 2009 Jan;32(1):187-92
19092168
Clin Ther. 2007;29 Spec No:1254-70
18046926
J Pharmacol Exp Ther. 2000 May;293(2):444-52
10773014
N Engl J Med. 2008 Jun 12;358(24):2560-72
18539916
Diabetes. 2005 Jun;54(6):1615-25
15919781
J Clin Endocrinol Metab. 2006 Mar;91(3):813-9
16352690
N Engl J Med. 2009 Oct 29;361(18):1736-47
19850703
Endocr Pract. 2009 Sep-Oct;15(6):540-59
19858063